Target intelligence / Profile preview

TMEM41A divergent transcript (TMEM41A-DT)

Target
TMEM41A-DT
Molecular classification
Long non-coding RNA (lncRNA), Other
01

Overview

TMEM41A divergent transcript (TMEM41A-DT; lnc-MAP3K13-3:1) is a long non-coding RNA transcribed in the vicinity of the TMEM41A gene, annotated as a "divergent transcript"[1]. Unlike TMEM41A, the associated protein, TMEM41A-DT does not encode a protein. Its sequence, regulatory properties, and role remain largely uncharacterized in the current literature. By gene ontology, most lncRNAs function through binding DNA, RNA, or proteins, thereby modulating chromatin structure, gene expression, or acting as molecular scaffolds, although the specific function of TMEM41A-DT is unknown[5]. There is no evidence that TMEM41A-DT is a therapeutic target, receptor, enzyme, transporter, or any classical druggable target. TMEM41A-DT has not been linked directly to disease mechanisms, biomarker status, or pharmacology.

Other names
lnc-MAP3K13-3:1TMEM41A-DT
02

Biological functions

Gene regulationPotential chromatin remodelingTranscriptional modulation
03

Disease associations

Other

Beyond the preview

Go deeper on TMEM41A divergent transcript (TMEM41A-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TMEM41A divergent transcript (TMEM41A-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call